视网类药物:在先发性病变和宫癌中的分子方面和治疗
Enoc Mariano Cortés-Malagón1,2, Patricio Gariglio3, Mónica Sierra-Martínez4
1Research Division, Hospital Juárez de México, Mexico City, Mexico.
Cancer control : journal of the Moffitt Cancer Center
|August 20, 2024
概括
持续高风险的人类乳头瘤病毒感染驱动子宫癌. 本综述探讨了维生素A代谢缺陷和子宫癌前期和癌症的视网治疗方法,提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 营养生物化学 营养生物化学
- 病毒学 病毒学
背景情况:
- 持续高风险的人类乳头瘤病毒 (HPV) 感染是宫皮状内皮损伤和宫癌的主要驱动因素.
- 宫癌的发展是一个复杂的过程,受遗传,免疫,荷尔蒙和营养因素的影响,这些因素协同作用.
- 视网类药物是维生素A的衍生物,在癌症发病和治疗相关的细胞过程中起着至关重要的作用.
研究的目的:
- 调查维生素A代谢缺陷与子宫癌之间的联系.
- 审查基于视网的疗法在治疗宫癌前病变和癌症方面的潜力.
- 在宫癌管理中整合视网类药物的流行病学和实验数据.
主要方法:
- 综合流行病学和实验发现的文献综述.
- 对维生素A代谢途径在子宫癌发生过程中的作用的分析.
- 评估视网类药物治疗的疗效,包括组合疗法.
主要成果:
- 维生素A代谢中的特定缺陷与子宫癌的发展有关.
- 视网类药物显示出作为治疗前恶性宫病变的治疗剂的潜力.
- 基于视网体的疗法显示出希望,无论是单一疗法还是组合疗法.
结论:
- 了解维生素A代谢缺陷,可以了解宫癌的发病原因.
- 视网类药物治疗是治疗宫内皮质瘤和宫癌的潜在策略.
- 对视网类药物治疗的进一步研究可能会为宫癌患者改善临床结果.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


